Akèy › Anplwayè › Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc.: Salè H-1B ak pajon
Vanda Pharmaceuticals Inc. depoze 19 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 19. Medyèn salè yo ofri a: $125,000.
Èske Vanda Pharmaceuticals Inc. pajone visa H-1B?
Vanda Pharmaceuticals Inc. depoze 19 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou May 29, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Clinical Data Manager | 4 | $92,500 |
| Bioinformatics Scientist | 3 | $145,000 |
| Sr. Statistical Analyst | 2 | $115,000 |
| Sr. Software Engineer | 2 | $170,000 |
| Sr. Scientist, Formulations Development | 1 | $125,500 |
| Senior CMC Regulatory Scientist | 1 | $138,000 |
| Manager, Statistical Programming | 1 | $130,000 |
| Senior Scientist, Analytical Chemistry | 1 | $125,000 |
| Manager, QA/CMC Regulatory | 1 | $119,000 |
| Statistical Analyst | 1 | $105,000 |
| Data Engineer | 1 | $100,000 |
| Director, Biostatistics | 1 | $230,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 4 | $131,750 |
| FY2024 | 7 | $120,000 |
| FY2025 | 5 | $100,000 |
| FY2026 | 3 | $170,000 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Statisticians6
- Data Scientists5
- Chemists3
- Molecular and Cellular Biologists2
- Software Developers2
- Medical Scientists, Except Epidemiologists1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Clinical Data Manager | $100,000–$115,000 Nivo I | Washington, DC | May 29, 2026 | Oct 1, 2026 | Certifye |
| Bioinformatics Scientist | $170,000–$190,000 Nivo III | Washington, DC | Apr 15, 2026 | Oct 1, 2026 | Certifye |
| Director, Biostatistics | $230,000–$245,000 Nivo IV | Washington, DC | Mar 23, 2026 | Apr 27, 2026 | Certifye |
| Data Engineer | $100,000–$115,000 Nivo I | Washington, DC | Sep 17, 2025 | Oct 20, 2025 | Certifye |
| Sr. Software Engineer | $170,000–$195,000 Nivo II | Washington, DC | May 6, 2025 | Jun 2, 2025 | Certifye |
| Sr. Software Engineer | $170,000–$195,000 Nivo II | Washington, DC | May 6, 2025 | Jun 2, 2025 | Certifye |
| Clinical Data Manager | $85,000–$95,000 Nivo I | Washington, DC | Apr 23, 2025 | Oct 1, 2025 | Certifye |
| Clinical Data Manager | $100,000–$110,000 Nivo I | Washington, DC | Apr 22, 2025 | Oct 1, 2025 | Certifye |
| Sr. Statistical Analyst | $120,000–$130,000 Nivo II | Washington, DC | Jul 31, 2024 | Sep 2, 2024 | Certifye |
| Statistical Analyst | $105,000–$115,000 Nivo I | Washington, DC | Jul 18, 2024 | Aug 19, 2024 | Certifye |
| Bioinformatics Scientist | $145,000–$155,000 Nivo II | Washington, DC | May 14, 2024 | May 25, 2024 | Certifye |
| Manager, QA/CMC Regulatory | $119,000–$129,000 Nivo II | Washington, DC | May 9, 2024 | Aug 30, 2024 | Certifye |
| Sr. Statistical Analyst | $110,000–$120,000 Nivo II | Washington, DC | Feb 1, 2024 | Feb 20, 2024 | Certifye, apre retire |
| Senior Scientist, Analytical Chemistry | $125,000–$135,000 Nivo II | Washington, DC | Jan 22, 2024 | Jul 1, 2024 | Certifye |
| Manager, Statistical Programming | $130,000–$150,000 Nivo II | Washington D.C, DC | Nov 21, 2023 | May 10, 2024 | Certifye |
| Clinical Data Manager | $80,000–$95,000 Nivo I | Washington DC, DC | Aug 2, 2023 | Oct 1, 2023 | Certifye |
| Bioinformatics Scientist | $140,000–$150,000 Nivo II | Washington, DC | Apr 5, 2023 | Oct 1, 2023 | Certifye |
| Senior CMC Regulatory Scientist | $138,000–$150,000 Nivo III | Washington, DC | Dec 23, 2022 | Jan 30, 2023 | Certifye |
| Sr. Scientist, Formulations Development | $125,500–$149,000 Nivo III | Washington, DC | Dec 21, 2022 | Jan 9, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).